Medscape (7/9, Tucker, Subscription Publication) reports, “Most antidepressant classes are associated with reduced mortality risk among people with both diabetes and major depression,” research indicated. The study, which included some 50,000 people, revealed “an approximate 35% reduction in deaths over the study period for all antidepressant classes except for reversible inhibitors of monoamine oxidase A.” The findingswere published online in the Journal of Clinical Endocrinology & Metabolism.
Related Links:
— “Antidepressant Use Cuts Deaths by a Third in Those With Diabetes, “Miriam E. Tucker, Medscape, July 9, 2019